A new genetic test to assess breast cancer risk in women who have a family history of the disease could be introduced into clinical practice in the UK within the next few months. Devised at Manchester University NHS Foundation Trust (MFT) and the University of Manchester, researchers believe the test for high-risk groups could also help reduce the number of women needing to have surgery to remove…
Up to the early 16th century, essentially medical diagnostics was limited to uroscopy – the observation of a urine sample in a uroscopy flask with a candle providing light. In a visual examination the doctor would determine the colour of the urine as well as cloudiness and precipitates, followed by a smell and taste test. The information he gathered provided the basis of his diagnosis. 100…
Bio-Rad Laboratories announces the launch of the "QXDx BCR-ABL %IS" Kit, the first CE-IVD digital PCR test that can monitor the molecular response of patients with chronic myeloid leukemia (CML) to therapy.
Agena Bioscience, a global provider of molecular genetic solutions, announced it has been selected to participate as an innovative technology provider in the ‘Liquid biopsies and IMAging for improved cancer care’ (LIMA) project. The LIMA project has been awarded a EUR 6.3 million Horizon 2020 European Union research grant to develop an integrated approach for personalized cancer treatment.…
Facilitating precise sample documentation and audience engagement, Olympus’ 18 megapixel SC180 camera shows unprecedented detail, especially at low magnifications. The easy-to-use and cost-effective SC180 camera reinforces Olympus’ commitment to making 4K Microscopy the new standard.
Gold nanoparticles could help make drugs act more quickly and effectively, according to new research conducted at Binghamton University, State University of New York. Nanoparticles are microscopic particles that are bigger than atoms but smaller than what the eye can see. They are unique for their large surface area-to-volume ratio and their fairly ubiquitous nature. A new study, co-conducted by…
In a comprehensive and complex molecular study of blood samples from Ebola patients in Sierra Leone, published in Cell Host and Microbe, a scientific team led by the University of Wisconsin–Madison has identified signatures of Ebola virus disease that may aid in future treatment efforts. Conducting a sweeping analysis of everything from enzymes to lipids to immune-system-associated molecules,…
DNAe, the inventor of semiconductor-based genomic analysis technologies, and the developer of a new, game-changing test for bloodstream infections that can lead to sepsis announced new data on its test for bloodstream infections, LiDia BSI. The data demonstrates the ability of the LiDia BSI closed cartridge-based test to rapidly identify low levels of bacterial and fungal pathogens and resistance…
EKF Diagnostics, the global in vitro diagnostics company, introduces POC Connect - a data management smartphone application for its DiaSpect Tm hemoglobin analyzer. At Medica 2017 on Stand H3/C70, EKF will be highlighting how DiaSpect Tm is the only reagent-free hemoglobin analyzer with mobile connectivity. Lightweight and palm-sized, the DiaSpect Tm analyzer delivers laboratory quality…
A Swiss hospital group is using drones to fly medical laboratory specimens between its key centres. In what is believed to be a world first, the eight-hospital Ticino EOC organisation has partnered with Swiss Post and US drone manufacturer Matternet to spearhead faster, more efficient specimens transport.
Providing insights into new cardiac testing methods, Professor Stefan Holdenrieder, Director of the Institute of Laboratory Medicine at Munich’s German Heart Centre, explained why biomarkers are a game changer in diagnostics.
The capillary blood collection system not only benefits geriatric patients, or those who need regular blood sampling, but also burns victims and others, including the youngest patients. All need a gentle approach. To that end, Austrian firm Greiner Bio-One has developed and optimised its MiniCollect system.
Just two decades ago, even though promising, point-of-care testing (POCT) was only used in hospitals and surgeries by a small number of specialists. Today POCT is in use throughout healthcare.
BBI Solutions (BBI), immunoassay developer and reagent supplier, acquired Maine Biotechnology Services Inc. (MBS) in July 2017, adding antibody development to the firm’s end to end assay development services. This also strengthens BBI’s reagents antibodies portfolio, providing a wide range of high quality biomarkers for infectious disease.
A new blood test to detect heart attacks has been developed by a team of researchers at King’s College, London, which could speed up diagnosis, according to results from pan-European trials. The test is quicker than the standard test, which combines an ECG with a blood test to measure the levels of troponin. Under current guidelines, suspected heart attack cases are tested for high blood…
Not long ago, POCT was a specialist diagnostic discipline used by only few laboratory staff. This has changed considerably over recent years. Initially, the main focus had been on determining electrolytes, blood gases, blood clotting and blood count, but further parameters, such as kidney function, cardiac enzymes, urine tests and testing for autoimmune diseases have now been added. Whilst the…
For POCT, point-of-care testing, a lab has to purchase new equipment, perform new measurements and handle new parameters – right? Right! However, more importantly, POCT requires the adaptation and integration of the existing lab organisation, with all its consequences, from additional quality control down to new areas of responsibility. Dr Herbert Stekel is currently integrating three…
Useful IT tools are abundant in today’s laboratories – ranging from software to evaluate analyses to specialist software for quality control, and middleware linking different devices. However, all these tools generate data, the adequate utilisation of which is not an easy task, said Udo Margraff, CEO of Laboratoires Réunis in Luxembourg, during our European Hospital interview. Among other…
Siemens Healthineers announced its Atellica NEPH 630 System is now available to laboratories. The Atellica NEPH 630 System is a low- to mid-volume nephelometric protein testing solution that simplifies laboratory operations by unifying instrument, assay, IT connectivity and remote service disciplines to deliver advancements in protein testing.
Just as for other medical fields, DICOM is expected to play a significant role in pathology as a universal and fundamental standard in digital medical imaging. The value chain of solution components in a digital pathology lab is both long and complex, which makes the adoption of standards as DICOM all the more important. "One of the visions driving DICOM in general is to give users the…
Researchers at the James Cook University Hospital, in Middlesbrough, UK, have developed a highly sensitive blood test that could be used before surgical operations to predict which patients are at risk of complications will survive in the long-term.
In the modern world, ergonomics is everywhere – and when microscopy is a big part of your daily routine, ergonomics should be at the forefront. Olympus’ BX53 microscope is designed with laboratory professionals in mind, allowing the microscope to be customized so that every user can work in their ideal posture.
Neagen and Visiopharm announce an integration which improves the data quality of cancer patient samples in a single PACS-driven digital pathology workflow also offering time and cost savings. This in term enhances quality for pathologists working in cancer research and diagnostics and benefits the patients.
Certain members of Generation Y, who grew up alongside enormous information technology (IT) advances, now occupy decision-making roles. Meanwhile, generation Z is emerging into the continuing IT revolution; the digital world surrounds us.
Over recent years, virology, once medicine‘s step-child, moved into the limelight, pushed by impressive progress and pulled by globalisation-induced need for expertise in virus diagnostics and viral epidemics.